| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0007 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0007 |
| mRNA | AZD-7545 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0008 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0009 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.099 | 0.0009 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | 0.13 | 0.001 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.19 | 0.001 |
| mRNA | BMS-536924 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.001 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |